Aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage

by Parc Científic de Barcelona (PCB)

With this operation, Aptadel Therapeutics begins a new stage of expansion to drive forward development of its pioneering treatment for Ewing’s sarcoma. The company is preparing a Series A funding ro...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

YIELCO Investments Celebrates Its 15th A...

by YIELCO Investments AG

Since its foundation in 2011, YIELCO has evolved into an international...

Photos Stream